Foghorn Therapeutics Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | $19.7M | $146.2M | $92.8M |
| FY2021 | $0 | $96.9M | $101.1M |
| FY2022 | — | $112.0K | $52.2M |
| FY2023 | — | $-77.2M | $80.3M |
| FY2024 | — | $-45.5M | $55.5M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | $19.7M | $146.2M | $92.8M |
| FY2021 | $0 | $96.9M | $101.1M |
| FY2022 | — | $112.0K | $52.2M |
| FY2023 | — | $-77.2M | $80.3M |
| FY2024 | — | $-45.5M | $55.5M |